13.1 Controlled & Semi-Controlled Medicines in the UAE

The Federal Control Framework

The UAE regulates controlled substances under federal law applied nationwide. The operative statute is Federal Decree-Law No. 30 of 2021 on Combating Narcotics and Psychotropic Substances, which governs narcotic drugs, psychotropic substances and their precursors. (The pharmacy-profession framework more broadly is Federal Decree-Law No. 38 of 2024, but controlled substances specifically fall under Decree-Law No. 30 of 2021.) The federal medicines regulator is the Emirates Drug Establishment (EDE), established in 2023 as the primary federal product regulator; it maintains and updates the official controlled and semi-controlled medicines lists, aligned with the three international drug-control treaties — the 1961 Single Convention on Narcotic Drugs, the 1971 Convention on Psychotropic Substances, and the 1988 Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances — and with the UN INCB schedules. The Ministry of Health and Prevention (MOHAP) formerly held these federal medicines functions; EDE now holds them at federal level, while the emirate-level health authorities (DHA in Dubai, DOH in Abu Dhabi, and MOHAP in the northern emirates) implement and enforce the rules in their facilities and pharmacies.

Schedule structure under Decree-Law No. 30 of 2021

Controlled substances are arranged into numbered schedules under the Decree-Law — this structure is examinable:

EDE maintains the official controlled and semi-controlled medicines lists and updates them by circular when substances are added, removed or reclassified, tracking changes to the international conventions and INCB schedules.

Controlled vs semi-controlled

The exam commonly tests the distinction between two practical tiers:

The precise lists change by EDE circular. Learn the principles and the statutory numbers below, and check the current EDE and Dubai Health circulars for exact substance placements.

Prescribing Requirements

A prescription for a controlled or semi-controlled medicine is valid only when it satisfies the formal requirements: written or transmitted through the Unified Platform electronic system by an appropriately licensed prescriber, with full patient identification, drug name, strength, form, dose, total quantity (with safeguards against alteration, such as quantity expressed in a tamper-evident manner), date and prescriber authentication. Key rules, drawn from the federal framework except where noted:

• Prescription validity. Prescriptions for narcotics, psychotropics and semi-controlled products are valid for 3 days from the date of issue. Stale-dated or post-dated prescriptions are refused after that window. Note that neither decree-law fixes this day-count itself: as Section 12.3 explains, it comes from MOHAP Ministerial Decree No. 888 of 2016 as applied through each emirate's implementation standard.
• No refills for narcotics. Repeat dispensing of a narcotic prescription is prohibited. Psychotropic and semi-controlled refill rules are set by the regulator.
• Prescriber restrictions. Some controlled medicines are restricted to specialists, hospitals or specific indications. A general-practitioner prescription for a substance reserved to specialists is not validly dispensable — verify, do not assume.
• Quantity limits. Prescriptions are capped at the quantities and percentages set out in Schedule 9 of Decree-Law No. 30 of 2021. Exceeding the cap is unlawful even with the patient's consent.
• No self or relative prescribing. A practitioner may not prescribe controlled or semi-controlled substances for themselves, their spouse, or relatives up to the second degree.
• No verbal or telephone supplies of controlled narcotics except within narrowly defined emergency provisions, which still require retrospective documentation.

Storage, Registers and Dispensing Checks

Storage. Narcotics and psychotropics must be stored in a tightly closed, locked cabinet or safe reserved for them, under the pharmacist's custody, within the secured pharmacy area, with access limited to the pharmacist in charge and authorised staff. Emirate-level standards — for example the DOH standard — specify double-locked steel cabinets and CCTV coverage. Keys or access codes are personally controlled — never left in the lock or shared on shift handover without a documented transfer.

Running-balance register and electronic recording. Controlled and semi-controlled prescribing is done via the Unified Platform electronic system. The pharmacy manager must record incoming and dispensed controlled substances in the electronic register on the same day the transaction occurs, and must send semi-annual stock statements (incoming, outgoing and remaining quantities) within the first 15 days of January and July. Every receipt and every supply is entered chronologically, showing the running stock balance after each transaction, with date, patient or supplier details, quantity and the responsible pharmacist's signature. Corrections are made by signed and dated annotation (never obliteration). Inspectors reconcile register balances against physical stock; an unexplained discrepancy is itself a reportable event.

Record retention. Registers, invoices and prescriptions for narcotics and psychotropics must be retained for at least 5 years; semi-controlled prescriptions must be retained for at least 2 years.

Dispensing checks. Before supplying, the pharmacist verifies the patient's identity (emirates ID or passport where required), confirms the prescription is genuine, within the 3-day validity window and within Schedule 9 quantity limits, checks the prescriber's authority to prescribe that substance, and records the supply in the electronic register on the same day. Suspected forgery — altered quantities, inconsistent handwriting, photocopied forms — means refuse to dispense, retain the prescription where safely possible, and report to the police and the health authority; never confront alone and never dispense an altered quantity.

Loss, Theft and Destruction

Loss, theft or breakage of controlled stock must be reported promptly to the police and the health authority, with the register annotated and an incident record kept. Controlled medicines are never thrown into general waste: destruction requires prior authorisation and witnessed destruction — an authorised inspector or committee member witnesses the process and both parties sign a destruction record, which is retained with the register.

Tramadol and Gabapentinoids — a Frequent Exam Target

The UAE tightened control of tramadol because of widespread misuse: it is treated under controlled-drug rules rather than as an ordinary analgesic, so ordinary repeat prescriptions and casual dispensing are unlawful. Pregabalin and gabapentin are likewise subject to tightened, semi-controlled-style control in the UAE and the wider Gulf region owing to dependence and diversion. Exam questions commonly hinge on recognising that these familiar medicines are not ordinary prescription-only items in the UAE and demand controlled-class vigilance.

Travellers and Personal Import

Patients entering the UAE with controlled or prescription medicines for personal use are expected to carry an attested medical prescription or doctor's report, keep medicines in original packaging, and limit quantities to personal therapeutic need — with stricter, smaller limits for controlled substances and, for some substances, a requirement for prior approval from the health authority before travel. Pharmacists should counsel travelling patients to check the current authority guidance before departure rather than rely on habit; several medicines freely available elsewhere are controlled in the UAE.

Penalties — Principle Level

Sanctions for unlawful possession, supply or record-keeping failures are set out in Schedule 10 of Decree-Law No. 30 of 2021 and range from professional discipline and licence action to criminal prosecution, with the severest penalties reserved for trafficking. For the exam, know the hierarchy of consequences — regulatory, professional, criminal — and the pharmacist's personal accountability as the custodian of the controlled-drug stock.